Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S (+) - Ibuprofen for Pain Control in Osteoarthritis
NCT04637529Phase 2Completed
- Sponsor
- Apsen Farmacêutica
- Start
- Aug 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexibuprofen in osteoarthritis (OA), sponsored by Apsen Farmacêutica. Started Aug 2022; status: completed.
02
Drugs
dexibuprofen
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04637529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04637529.